FCN3
Basic information
Region (hg38): 1:27369110-27374824
Links
Phenotypes
GenCC
Source:
- immunodeficiency due to ficolin3 deficiency (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Ficolin 3 deficiency | AR | Allergy/Immunology/Infectious | Sequelae have been described as including frequent and severe infections, and antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial | Allergy/Immunology/Infectious | 19535802 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (46 variants)
- not_provided (10 variants)
- Immunodeficiency_due_to_ficolin3_deficiency (9 variants)
- FCN3-related_disorder (6 variants)
- Microcephaly (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FCN3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003665.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | |||||
| missense | 46 | 51 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 3 | |||||
| splice donor/acceptor (+/-2bp) | 2 | |||||
| Total | 0 | 2 | 49 | 8 | 0 |
Highest pathogenic variant AF is 0.00003159922
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| FCN3 | protein_coding | protein_coding | ENST00000270879 | 8 | 5713 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.00380 | 0.961 | 125306 | 2 | 426 | 125734 | 0.00170 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.422 | 162 | 178 | 0.911 | 0.0000106 | 1922 |
| Missense in Polyphen | 55 | 55.073 | 0.99867 | 653 | ||
| Synonymous | 1.67 | 50 | 67.4 | 0.742 | 0.00000383 | 598 |
| Loss of Function | 1.84 | 6 | 13.2 | 0.454 | 5.64e-7 | 149 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00508 | 0.00501 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0000544 | 0.0000544 |
| Finnish | 0.000695 | 0.000693 |
| European (Non-Finnish) | 0.00250 | 0.00248 |
| Middle Eastern | 0.0000544 | 0.0000544 |
| South Asian | 0.000392 | 0.000392 |
| Other | 0.00229 | 0.00228 |
dbNSFP
Source:
- Function
- FUNCTION: May function in innate immunity through activation of the lectin complement pathway. Calcium-dependent and GlcNAc- binding lectin. Has affinity with GalNAc, GlcNAc, D-fucose, as mono/oligosaccharide and lipopolysaccharides from S.typhimurium and S.minnesota. {ECO:0000269|PubMed:11907111, ECO:0000269|PubMed:17215869}.;
- Disease
- DISEASE: Ficolin 3 deficiency (FCN3D) [MIM:613860]: A disorder characterized by immunodeficiency, recurrent infections, brain abscesses and recurrent warts on the fingers. Affected individuals have normal levels of lymphocytes, normal T-cell responses, and normal antibodies, but a selective deficient antibody response to pneumococcal polysaccharide vaccine. {ECO:0000269|PubMed:19535802}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Innate Immune System;Immune System;Initial triggering of complement;Ficolins bind to repetitive carbohydrate structures on the target cell surface;Lectin pathway of complement activation;Creation of C4 and C2 activators;Complement cascade
(Consensus)
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- loftool
- 0.600
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.6
Haploinsufficiency Scores
- pHI
- 0.0966
- hipred
- N
- hipred_score
- 0.198
- ghis
- 0.439
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.139
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- complement activation, lectin pathway;proteolysis;complement activation;recognition of apoptotic cell;negative regulation of viral entry into host cell;defense response to virus;negative regulation of RNA biosynthetic process
- Cellular component
- extracellular region;collagen trimer;blood microparticle
- Molecular function
- antigen binding;serine-type endopeptidase activity;protein binding;carbohydrate binding;metal ion binding